Total Payments
$258,978
2023 Payments
$50.22
Companies
17
Transactions
338
Payment Breakdown by Category
Other$177,000 (68.3%)
Travel$34,798 (13.4%)
Consulting$32,825 (12.7%)
Research$7,620 (2.9%)
Food & Beverage$6,728 (2.6%)
Education$7.09 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $142,005 | 41 | 54.8% |
| Honoraria | $34,995 | 15 | 13.5% |
| Travel and Lodging | $34,798 | 155 | 13.4% |
| Consulting Fee | $32,825 | 9 | 12.7% |
| Unspecified | $7,620 | 7 | 2.9% |
| Food and Beverage | $6,728 | 110 | 2.6% |
| Education | $7.09 | 1 | 0.0% |
Payments by Type
General
$251,358
331 transactions
Research
$7,620
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $164,406 | 217 | $0 (2019) |
| CSL Behring | $25,915 | 32 | $0 (2019) |
| PFIZER INC. | $20,990 | 19 | $0 (2022) |
| BioCryst US Sales Co., LLC | $13,092 | 13 | $0 (2023) |
| BioCryst Pharmaceuticals, Inc. | $11,841 | 16 | $0 (2020) |
| Pharming Healthcare, Inc. | $11,128 | 15 | $0 (2021) |
| Fresenius Kabi USA, LLC | $5,798 | 4 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $3,538 | 3 | $0 (2020) |
| Roche Products Limited | $1,376 | 3 | $0 (2017) |
| Kaleo, Inc. | $329.58 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $50.22 | 1 | BioCryst US Sales Co., LLC ($50.22) |
| 2022 | $4,520 | 4 | PFIZER INC. ($4,470) |
| 2021 | $13,007 | 12 | BioCryst US Sales Co., LLC ($12,992) |
| 2020 | $12,211 | 10 | BioCryst Pharmaceuticals, Inc. ($5,500) |
| 2019 | $81,502 | 97 | Shire North American Group Inc ($57,678) |
| 2018 | $88,190 | 129 | Shire North American Group Inc ($86,954) |
| 2017 | $59,498 | 85 | CSL Behring ($22,221) |
All Payment Transactions
338 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/09/2023 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $50.22 | General |
| Category: Immunology | ||||||
| 12/23/2022 | PFIZER INC. | EUCRISA (Drug) | — | In-kind items and services | $3,200.00 | Research |
| Study: CRISABOROLE CLINICAL PUBLICATION PROGRAM • Category: DERMATOLOGY | ||||||
| 06/21/2022 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $49.92 | General |
| Category: Immunology | ||||||
| 06/17/2022 | PFIZER INC. | EUCRISA (Drug) | — | In-kind items and services | $940.00 | Research |
| Study: CRISABOROLE CLINICAL PUBLICATION PROGRAM • Category: DERMATOLOGY | ||||||
| 04/18/2022 | PFIZER INC. | EUCRISA (Drug) | — | In-kind items and services | $330.00 | Research |
| Study: CRISABOROLE CLINICAL PUBLICATION PROGRAM • Category: DERMATOLOGY | ||||||
| 12/17/2021 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: BIOLOGIC | ||||||
| 09/24/2021 | BioCryst US Sales Co., LLC | Orladeyo (Drug) | Consulting Fee | Cash or cash equivalent | $4,125.00 | General |
| Category: Immunology | ||||||
| 09/24/2021 | BioCryst US Sales Co., LLC | Orladeyo (Drug) | Food and Beverage | In-kind items and services | $109.97 | General |
| Category: Immunology | ||||||
| 09/24/2021 | BioCryst US Sales Co., LLC | Orladeyo (Drug) | Travel and Lodging | In-kind items and services | $36.40 | General |
| Category: Immunology | ||||||
| 05/18/2021 | BioCryst US Sales Co., LLC | Orladeyo (Drug) | Food and Beverage | Cash or cash equivalent | $117.61 | General |
| Category: Immunology | ||||||
| 05/12/2021 | BioCryst US Sales Co., LLC | Orladeyo (Drug) | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: Immunology | ||||||
| 04/30/2021 | BioCryst US Sales Co., LLC | Orladeyo (Drug) | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| Category: Immunology | ||||||
| 04/30/2021 | BioCryst US Sales Co., LLC | Orladeyo (Drug) | Food and Beverage | In-kind items and services | $49.31 | General |
| Category: Immunology | ||||||
| 03/30/2021 | BioCryst US Sales Co., LLC | Orladeyo (Drug) | Consulting Fee | Cash or cash equivalent | $1,375.00 | General |
| Category: Immunology | ||||||
| 03/30/2021 | BioCryst US Sales Co., LLC | Orladeyo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: Immunology | ||||||
| 03/25/2021 | BioCryst US Sales Co., LLC | Orladeyo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: Immunology | ||||||
| 01/20/2021 | BioCryst US Sales Co., LLC | Orladeyo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,650.00 | General |
| Category: Immunology | ||||||
| 10/16/2020 | BioCryst Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| 10/07/2020 | Takeda Pharmaceuticals U.S.A., Inc. | CINRYZE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/05/2020 | PFIZER INC. | EUCRISA (Drug) | — | In-kind items and services | $940.00 | Research |
| Study: CRISABOROLE CLINICAL PUBLICATION PROGRAM • Category: DERMATOLOGY | ||||||
| 10/02/2020 | Takeda Pharmaceuticals U.S.A., Inc. | CINRYZE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 05/09/2020 | BioCryst Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| 05/02/2020 | PFIZER INC. | EUCRISA (Drug) | — | In-kind items and services | $940.00 | Research |
| Study: CRISABOROLE CLINICAL PUBLICATION PROGRAM • Category: DERMATOLOGY | ||||||
| 05/01/2020 | PFIZER INC. | EUCRISA (Drug) | — | In-kind items and services | $330.00 | Research |
| Study: CRISABOROLE CLINICAL PUBLICATION PROGRAM • Category: DERMATOLOGY | ||||||
| 03/24/2020 | PFIZER INC. | EUCRISA (Drug) | — | In-kind items and services | $940.00 | Research |
| Study: CRISABOROLE CLINICAL PUBLICATION PROGRAM • Category: DERMATOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| CRISABOROLE CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $7,620 | 7 |
About Dr. Richard Gower, MD
Dr. Richard Gower, MD is a Allergy & Immunology healthcare provider based in Spokane, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1619969557.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Gower, MD has received a total of $258,978 in payments from pharmaceutical and medical device companies, with $50.22 received in 2023. These payments were reported across 338 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($142,005).
Ad
Practice Information
- Specialty Allergy & Immunology
- Location Spokane, WA
- Active Since 08/17/2005
- Last Updated 10/24/2012
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1619969557
Products in Payments
- CINRYZE (Drug) $151,703
- Haegarda (Biological) $25,685
- EUCRISA (Drug) $20,990
- TAKHZYRO (Biological) $16,229
- Orladeyo (Drug) $12,992
- RUCONEST (Biological) $11,128
- PH-Icatibant (Drug) $5,798
- Xolair (Biological) $1,459
- Auvi-Q (Drug) $329.58
- NUCALA (Biological) $117.71
- ORLADEYO (Drug) $100.14
- Hizentra (Biological) $100.00
- DUPIXENT (Drug) $90.51
- XOLAIR (Biological) $81.66
- Product in Development (Biological) $78.63
- Xhance (Drug) $60.84
- Berinert 500U (Biological) $51.82
- FEVIPIPRANT (Drug) $34.83
- RESLIZUMAB (Drug) $27.95
- NASAL POLYPOSIS - DISEASE (Drug) $24.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in Spokane
Steven Kernerman, D.o, D.O
Allergy & Immunology — Payments: $5,338
Allergy & Immunology $5,338
Dr. Ronald England, Md, MD
Allergy & Immunology — Payments: $4,549
Allergy & Immunology $4,549
Kerry Drain, M.d, M.D
Allergy & Immunology — Payments: $1,462
Allergy & Immunology $1,462
Rayna Traen, Do, DO
Allergy & Immunology — Payments: $967.27
Allergy & Immunology $967.27
Dr. Michael Kraemer, M.d, M.D
Allergy & Immunology
Allergy & Immunology
Terance Kordash, Md, MD
Allergy & Immunology
Allergy & Immunology